Who is sponsoring NCT03725163?

NCT03725163 is sponsored by Utah State University.

What drugs are being tested in NCT03725163?

Interventions in NCT03725163: Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT).

What condition does NCT03725163 study?

NCT03725163 studies Trichotillomania.

Is NCT03725163 still recruiting?

NCT03725163 is currently status unknown. Last updated 30 October 2018.

Last reviewed 2018-10-30 · How we verify

NCT03725163

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telepsychotherapy for the Treatment of Adolescents With Trichotillomania

Status unknown NA Last updated 30 October 2018

What this trial tests

NA trial testing Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT) in Trichotillomania in 60 participants. Status unknown.

Timeline

6 August 2018

Primary endpoint
5 August 2020

5 August 2020

Quick facts

Lead sponsor	Utah State University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	6 August 2018
Primary completion	5 August 2020
Estimated completion	5 August 2020
Sites	1 location across United States

Drugs / interventions tested

Acceptance and Commitment Therapy Enhanced Behavior Therapy (AEBT)

Conditions studied

Trichotillomania — all drugs for Trichotillomania →

Sponsor

Utah State University

Who can join

Adults 12 to 17, any sex, with Trichotillomania. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of the current study is to evaluate the effectiveness of providing treatment for adolescents with trichotillomania through the use of telehealth. Parent or legal guardians' psychological flexibility scores will be assessed to determine if their levels of flexibility potentially moderate treatment outcomes. The study will test the following hypotheses: Hypothesis 1: Telepsychotherapy will result in significantly better trichotillomania symptom outcomes for adolescents than a waitlist control condition. Hypothesis 2: Telepsychotherapy will result in significantly better psychological flexibility outcomes for adolescents than a waitlist control condition. Hypothesis 3: Telepsychotherapy will result in significantly better overall wellbeing outcomes for adolescents than a waitlist control condition. Hypothesis 4: Within-group changes (that include both conditions following treatment) will be significant from pre-treatment to post-treatment and will not significantly differ from post-treatment at 3, 6, and 12-month follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Trichotillomania

Currently open trials in the same condition.

NCT07224126 — Technology Assisted Treatment of Trichotillomania: Open Trial · NA · recruiting
NCT02747771 — Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder) · recruiting

Other Utah State University trials

Trials by the same sponsor.

NCT06768775 — The Impact of Pastured Livestock Food Consumption on Fatty Acid and Metabolomic Profiles · NA · completed
NCT04977804 — Eccentric Resistance Training With Blood Flow Restriction on Muscle Function · NA · withdrawn
NCT06232642 — Effects of Lactoferrin-enriched Whey on Iron Status in Females · NA · active not recruiting
NCT06179264 — Evaluating an Online Acceptance and Commitment Training Program for Individuals with Chronic Health Conditions · NA · completed
NCT06139718 — Examining the Efficacy of a Single Session Online Mental Health Program · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03725163 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Utah State University
Last refreshed: 30 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03725163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing